US Stock Movement: ORIC Pharmaceuticals surges on October 15 as JPMorgan raises target price and innovative oncology drugs
Bitget异动解读2026/10/15 20:00ORIC Pharmaceuticals Surge on October 15 Explained
Keywords: JPMorgan raises target price, Innovative oncology drugs
Date unspecified, JPMorgan maintains a Buy rating and raises ORIC's target price from $23 to $26.
(Disclaimer: This content is generated by AI technology based on publicly available information for reference only and does not constitute investment advice.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
INE crude oil main contract reported at 719.6 yuan/barrel, down 1.68% during the day
Vietnam BSR refinery says it has secured crude oil supply until the end of the year
Crypto prices
More
